Amy Ratner - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Amy Ratner's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Amy Ratner
Verified
Medical and Science News Analyst, Beyond Celiac
Baltimore
Beats
food sustainable fashion travel home design
Content
Potential drug to treat celiac disease prevents damage caused by gluten in recent study of molecular action
By Amy Ratner Verified| Beyond Celiac Verified July 9, 2024Researchers look at what’s happening inside cells in latest study of ZED1227By Amy Ratner, director of scientific affairsA new study that analyzed the activity of more than 10,000 genes found that a drug being investigated to treat celiac disease prevented intestinal damage caused by gluten. The research focused on the molecular mechanism of ZED1227, a treatment designed to block transglutaminase 2 (TTG), an enzyme that reacts with fragments of gluten.
By Amy Ratner Verified| Beyond Celiac Verified September 19, 2023Symptoms are not a reliable way to determine gluten exposure, but urine and stools tests might helpBy Amy Ratner, director of scientific affairsIn children with celiac disease, it can be a challenge to connect the dots between any gluten getting into the child’s diet and the consequences, especially if the child does not have any symptoms.
Potential drug to treat celiac disease prevents damage caused by gluten in recent study of molecular action
By Amy Ratner Verified| Beyond Celiac Verified July 9, 2024Researchers look at what’s happening inside cells in latest study of ZED1227By Amy Ratner, director of scientific affairsA new study that analyzed the activity of more than 10,000 genes found that a drug being investigated to treat celiac disease prevented intestinal damage caused by gluten. The research focused on the molecular mechanism of ZED1227, a treatment designed to block transglutaminase 2 (TTG), an enzyme that reacts with fragments of gluten.
Company Info
Beyond Celiac
Beyond Celiac is a non-profit organization focused on raising awareness of celiac disease and gluten-related disorders. Founded in 2003, it aims to improve diagnosis rates, advance research, and promote the discovery of new treatments and a cure for celiac disease. The organization is led by Alice Bast, who envisions a world where individuals with celiac disease can live safely and fully. The mission of Beyond Celiac includes advocating for access to high-quality healthcare and safe gluten-free food options. It engages with researchers and the community to enhance the quality of life for those affected by celiac disease. The organization also fosters an online community to involve individuals in research efforts, aiming to explore treatments beyond the gluten-free diet.
Baltimore, United States
+1 215-325-1306
Founded: 2003